BioReperia
PrivateLast Round
Grant
Apr 13, 2021
Total Funding Raised
$1.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BioReperia is a biotechnology company that provides a zebrafish tumor xenograft (ZTX®) platform used to accelerate drug discovery and predict the efficacy of cancer treatments for personalized medicine.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioReperia Comparables
Compare BioReperia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ZeClinics | 84% | |
| Hunter Biotechnology | 78% | |
| Zefit | 77% |
BioReperia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 13, 2021 | ||||
| Series A | Jul 1, 2019 |
Key People
Founding team and executive leadership
BioReperia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LiU Invest | Seed |
| Almi Invest AB | Series A |
| Swelife | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 43% MoM.
- Jun 22, 2026
Monthly visitors increased 49% MoM.
Recent news
Latest coverage and updates
- partners_withAug 12, 2026
BioReperia partnered with Telomir Pharmaceuticals, Inc. on Apr 1st '26.
BioReperia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioReperia's valuation, stock price, and market status.
Is BioReperia a public or private company?
BioReperia is a private company.
What is the current stock price of BioReperia?
BioReperia is a private company with no public stock price. No recent secondary market data is available.
How much is BioReperia worth (valuation)?
Valuation information for BioReperia is not publicly available.
Can I buy BioReperia stock?
BioReperia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioReperia's last funding round?
BioReperia's most recent funding round was Grant on April 13, 2021.
Who are the main investors in BioReperia?
Key investors in BioReperia include Almi Invest AB.
Will BioReperia IPO soon?
No public IPO plans have been announced for BioReperia.
How can I track BioReperia secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioReperia's secondary market activity and sign up for updates.